PofoliaShared via Pofolia

Journal of Advanced Research· 2020Q1· Review

COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses

Muhammad Adnan Shereen, Suliman Khan, Abeer Kazmi, Nadia Bashir et al.

Short summary

SARS-CoV-2, the virus causing COVID-19, emerged in Wuhan, China, and is a highly transmittable pathogen related to bat coronaviruses, with rapid human-to-human spread confirmed.

AI-generated from the title and abstract; the full text is not read.

Key points

  • COVID-19 is caused by SARS-CoV-2, which emerged in Wuhan, China.
  • SARS-CoV-2 is phylogenetically related to SARS-like bat viruses, suggesting bats as a possible reservoir.
  • Rapid human-to-human transmission of SARS-CoV-2 has been widely confirmed.
  • No clinically approved antiviral drugs or vaccines are currently available for COVID-19.

AI-generated from the title and abstract; the full text is not read.

Abstract

The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in Wuhan, China and spread around the world. Genomic analysis revealed that SARS-CoV-2 is phylogenetically related to severe acute respiratory syndrome-like (SARS-like) bat viruses, therefore bats could be the possible primary reservoir. The intermediate source of origin and transfer to humans is not known, however, the rapid human to human transfer has been confirmed widely. There is no clinically approved antiviral drug or vaccine available to be used against COVID-19. However, few broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical trials, resulted in clinical recovery. In the current review, we summarize and comparatively analyze the emergence and pathogenicity of COVID-19 infection and previous human coronaviruses severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV). We also discuss the approaches for developing effective vaccines and therapeutic combinations to cope with this viral outbreak.

The authors' abstract, as published at the source. Journal of Advanced Research, 2020 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Infectious Diseases

Infectious DiseasesMedicine